Skip to main content
SpringerLink
Log in

Adalimumab/infliximab

CNS demyelination and neurological symptoms: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Papatheodoridi M, et al. Neurological symptoms and imaging abnormalities in brain MRI in patients with Crohn's disease receiving anti-TNFa therapy. Journal of Crohn's and Colitis 13 (Suppl. 1): S290-S291 abstr. P372, Mar 2019. Available from: URL: http://doi.org/10.1093/ecco-jcc/jjy222.496 [abstract] -Greece

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab. Reactions Weekly 1762, 18 (2019). https://doi.org/10.1007/s40278-019-64757-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-64757-y

Search

Navigation